Why didn’t they report p values for this trial? That’s the whole point of doing a trial with a control arm.
Based off this I’d say they’ve missed the mark.
Let’s see what the market thinks, but I feel as though the capital raise before the data proved that the data wasn’t going to be great and that thought seems to be validated.
The top line result is 32.8% vs 26.7% but I guarantee they’ll try to spin it.
Ann: Webcast slides for new Efti clinical data in 1st line HNSCC, page-3
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.020(6.67%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.3¢ | 30.0¢ | $1.040M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 42705 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |